Use of monoamine oxidase inhibitors in chronic neurodegeneration.

Use of monoamine oxidase inhibitors in chronic neurodegeneration.

Item
http://www.wikidata.org/entity/Q39044780
Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease.Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease.Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.MAO inhibitors and their wider applications: a patent review.Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.Antidepressant Flavonoids and Their Relationship with Oxidative Stress.Safinamide: an add-on treatment for managing Parkinson's disease.The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).
P2860

Use of monoamine oxidase inhibitors in chronic neurodegeneration.

Item
http://www.wikidata.org/entity/Q39044780
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@en
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@nl
type
label
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@en
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@nl
prefLabel
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@en
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Use of monoamine oxidase inhibitors in chronic neurodegeneration.
@en
P2093
P2860
P304
P31
P356
10.1080/17425255.2017.1273901
P407
P433
P478
P577
P698